United States
# |
Name |
Price to Book Ratio (P/B) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
41.64 |
Feb. 5, 2025 | USD 114.00 | 0.96% |
|
United States |
|
2 |
15.51 |
Feb. 5, 2025 | USD 127.03 | 0.10% |
|
United States |
|
3 |
12.53 |
Feb. 5, 2025 | USD 68.45 | 2.30% |
|
United States |
|
4 |
11.08 |
Feb. 5, 2025 | USD 39.14 | -0.43% |
|
United States |
|
5 |
9.71 |
Feb. 5, 2025 | USD 16.90 | 3.81% |
|
United States |
|
6 |
8.03 |
Feb. 5, 2025 | USD 3.27 | -5.22% |
|
United States |
|
7 |
6.67 |
Feb. 5, 2025 | USD 29.00 | 1.22% |
|
United States |
|
8 |
6.22 |
Feb. 5, 2025 | USD 151.20 | -0.80% |
|
United States |
|
9 |
3.75 |
Feb. 5, 2025 | USD 31.32 | 1.36% |
|
United States |
|
10 |
3.06 |
Jan. 31, 2025 | USD 23.60 | -2.64% |
|
United States |
|
11 |
2.92 |
Feb. 5, 2025 | USD 33.39 | 0.18% |
|
United States |
|
12 |
2.18 |
Feb. 5, 2025 | USD 8.15 | 1.24% |
|
United States |
|
13 |
1.75 |
Feb. 5, 2025 | USD 20.29 | 0.50% |
|
United States |
|
14 |
1.67 |
Feb. 5, 2025 | USD 101.78 | 0.11% |
|
United States |
|
15 |
1.44 |
Feb. 5, 2025 | USD 45.00 | -0.13% |
|
United States |
|
16 |
1.40 |
Feb. 5, 2025 | USD 6.90 | -0.14% |
|
United States |
|
17 |
1.12 |
Feb. 5, 2025 | USD 60.73 | -0.91% |
|
United States |
|
18 |
0.99 |
Feb. 5, 2025 | USD 11.00 | 5.77% |
|
United States |
|
19 |
0.75 |
Feb. 5, 2025 | USD 2.95 | 3.15% |
|
United States |
|
20 |
0.70 |
Feb. 5, 2025 | USD 3.56 | 0.85% |
|
United States |
|
21 |
0.67 |
Feb. 5, 2025 | USD 8.65 | 1.88% |
|
United States |
|
22 |
-116.20 |
Feb. 5, 2025 | USD 6.38 | 0.95% |
|
United States |
The Mental Health company in United States with the highest Price to Book Ratio (P/B) is Axsome Therapeutics, Inc. (NasdaqGM: AXSM) at 41.64.
The Mental Health company in United States with the lowest Price to Book Ratio (P/B) is LifeMD, Inc. (NasdaqGM: LFMD) at -116.20.
The top 10 Mental Health companies in United States by Price to Book Ratio (P/B) are Axsome Therapeutics, Inc., Intra-Cellular Therapies, Inc., Corcept Therapeutics Incorporated, Biohaven Pharmaceutical Holding Company Ltd., National Research Corporation, Neuronetics, Inc., Phreesia, Inc., Neurocrine Biosciences, Inc., Option Care Health, Inc. and BrightSpring Health Services, Inc. Common Stock.
The bottom 10 Mental Health companies in United States by Price to Book Ratio (P/B) are LifeMD, Inc., Enhabit, Inc., Waldencast plc, VistaGen Therapeutics, Inc., Teladoc Health, Inc., Centene Corporation, Accolade, Inc., Acadia Healthcare Company, Inc., National HealthCare Corporation and Select Medical Holdings Corporation.